Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Review Article

RMJ. 2004; 29(2): 80-81


Harmone replacement therapy in postmenopausal women

Nadira Sultana, Irum Sohail, Farzana Yusuf.

Abstract
When menopause sets in many women experience physical and psychological changes. These changes are mostly due to the deficiency of female hormones, namely estrogen and progesterone. To counteract these changes, these hormones are given to women and this is called “hormone replacement therapy” (HRT).

Initially, in the 1950’s estrogen1 alone was used, but 25 years ago the risk of endometrial cancer emerged. Hence in the 1980’s progesterone was added. A randomized trial of the combined therapy was started which showed increased risk of carcinoma of breast, coronary heart disease, stroke and venous thromboembolism, hence the trial was stopped early2

Later on other drugs, like Tibolone,3 were introduced, which is a synthetic steroid with weak estrogenic, androgenic and progesterone like properties. Then, selective estrogen receptor modulators (SERMS), which include raloxifene4 were introduced. This is used in the treatment of osteoporosis in postmenopausal women and to prevent vertebral fractures. Then Biphosphonates were used for osteoporosis, but later were shown that they promote bones to become brittle.5

Key words: HRT, estrogens, menopause



Similar Articles

Fetal Estrogens are not Involved in Sex Determination But Critical for Early Ovarian Differentiation in Rabbits.
Jolivet G, Daniel-Carlier N, Harscoët E, Airaud E, Dewaele A, Pierson C, Giton F, Boulanger L, Daniel N, Mandon-Pépin B, Pannetier M, Pailhoux E
Endocrinology. 2022; 163(1):

Estrogens still represent an attractive therapeutic approach for Alzheimer's disease.
Tamagno E, Guglielmotto M
Neural regeneration research. 2022; 17(1): 93-94

Effects of heavy metal, vitamin, and curry consumption on metabolic syndrome during menopause: a Korean community-based cross-sectional study.
Nguyen HD, Kim MS
Menopause (New York, N.Y.). 2021; ():

The impact of metformin on prolactin levels in postmenopausal women.
Krysiak R, Kowalcze K, Okopień B
Journal of clinical pharmacy and therapeutics. 2021; ():

A research primer for studies of cognitive changes across the menopause transition.
Maki PM, Weber MT
Climacteric : the journal of the International Menopause Society. 2021; 24(4): 382-388


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites